Global Cell Therapy Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research new Market report, global cell therapy market accounted to USD 5.35 billion in 2018 growing at a CAGR of 5.6% during the forecast period of 2019 to 2026.

Access Full Report at

Global Cell Therapy Market

The Cell therapy is a type of therapy in which live cells that can be injected into a patient for the treatment of a number of disorders. Like, T-Cells are injected for the treatment of cancer as they are capable to fighting with cancer cells during the immunotherapy treatment course.

Segmentation: Global Cell Therapy Market

Global cell therapy market is segmented on the basis of Type, Technology, Cell Source, Application, End User and geography.

By Type (Autologous, Allogeneic), Technology (Somatic Cell, Immortalized Cell, others), Cell Source (Ipscs, Bone Marrow, others), Application (Musculoskeletal, Neurological, others) End User (Hospital & Clinics, Regenerative Medicine Centers, Diagnostic Centers, Research Institutes, Others) and Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)


Rising Geriatric Population

According to United Nations Department of Economic and Social Affairs/Population Division; in 2017, estimated population of people with age 60 or above was 962 million, which means around 13 per cent of the population. This age bracket or group is growing at a rate of 3 per cent every year. Presently, Europe is leading the other regions in terms of population consisting of this age group. This brisk speed of ageing is expected to carry on in other regions as well, which projects that by the end of 2050 excluding Africa all regions of the world would have more than a quarter share of their total population at an age of 60 years and above. The population of this age group is projected to reach around 1.40 billion in 2030 and 2.10 billion in 2050, and could ultimately rise up to 3.10 billion in 2100.

Key Market Competitors: Global Cell Therapy Market

Few of the major competitors currently working in the cell therapy market are Vericel, Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., MEDIPOST, Osiris, Stemedica Cell Technologies Inc., NuVasive Inc., Fibrocell Science Inc., Cellectis, BioNTech IMFS, pluristem, Grupo Praxis, Genzyme Corporation, Advanced Tissue, Cells for Cells, PHARMICELL Co. Ltd, ANTEROGEN.CO.LTD., Novartis AG, GlaxoSmithKline plc, CELGENE CORPORATION, Bone Therapeutics, Cell Therapies, Celyad, Regen BioPharma, Cellular Therapeutics Ltd, TxCell, and Advancells.

Browse Related Reports:

Global Cell Therapy Market By Type (Autologous, Allogeneic), Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds & Injuries, Ocular, Others), End-User (Hospitals & Clinics, Regenerative Medicine Centers, Diagnostic & Research Centers, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Global Stem Cell Therapy Market, By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Applications (Musculoskeletal Disorders, Wounds, Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), End Users (Therapeutic Companies, Cell And Tissues Banks, Tools And Reagent Companies, Service Companies), Geography (Asia North America, South America, Europe, Asia-Pacific, Middle East And Africa)– Industry Trends and Forecast to 2025

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Applications (Eurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, Cardiovascular Diseases), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By End User (Hospitals And Ambulatory Surgical Center), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025